Cerenome subsidiary signs in-network deal with BCBSM for CNSide coverage
CNSide Diagnostics, a Cerenome subsidiary, signed an in-network provider agreement with Blue Cross Blue Shield of Michigan effective September 1, expanding CNSide® contracted coverage to about 158 million covered lives.
HOUSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) (“Cerenome” or the “Company”), said it has signed an in-network provider agreement with Blue Cross Blue Shield of Michigan (“BCBSM”) for CNSide coverage, effective September 1…